The information on this page is based on a number of underlying datasets, most of which are updated monthly. We maintain an update schedule which explains which version of each dataset we are currently relying on.
39 GILLQUART WAY is a small flat of 50m², built sometime between 1996 and 2002, which could now be worth an estimated £216,838. It was last sold for £87,400 in May 2002, which was around 72% above the average May 2002 flat price in the Coventry local authority area. The most recent EPC inspection was July 2020, where the current energy rating was C, and the potential energy rating was C.
Land registry data shows one sale for 39 GILLQUART WAY since 1st January 1995. The below table shows the price paid for the one sale, along with the average flat price in the Coventry local authority area for the corresponding sale date. The average price is sourced from the Office for National Statistics' House Price Index (HPI).
| Date | Price | HPI Price | Variation from HPI |
|---|---|---|---|
2002 28 MAY | £87,400 | £50,871 | 72% above HPI |
39 GILLQUART WAY might now be worth an estimated £216,838.
This is based on house price inflation of 148.1%, between May 2002 and May 2026, for flats, in the Coventry local authority area, as calculated by the Office for National Statistics and published in their UK House Price Index (HPI).
The 148.1% inflationary increase is applied to the most recent sale price for 39 GILLQUART WAY of £87,400 on 28th May 2002. For the value to have increased from £87,400 to £216,838 over the 24 years to May 2026, the following assumptions must hold true:
39 GILLQUART WAY is 50m² according to the EPC inspection conducted in July 2020. This puts it in the smallest 30% of flats in Coventry, based on EPC data. 23% of flats are smaller than 39 GILLQUART WAY, and 74% of flats are larger. Note that EPC data is not available for all properties in Coventry.
39 GILLQUART WAY sits on a plot of roughly 3.2 acres, or 13,055m².
39 GILLQUART WAY is located in COVENTRY, in the CV1 postcode district.
Most recent sales first: